List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 45 studies with search of: Lamivudina/ zidovudina OR Combivir[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Switch From Combivir to Truvada - Mitochondrial Effects
Conditions: HIV;   HIV Infections
Intervention: Drug: Truvada vs Combivir
2 Completed A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
Condition: HIV Infection
Interventions: Drug: Trizivir;   Drug: atazanavir;   Drug: Combivir
3 Not yet recruiting Atazanavir or Lopinavir in HIV Post-Exposure Prophylaxis
Condition: HIV Infections
Interventions: Drug: Combivir+Kaletra;   Drug: Combivir+Reyataz
4 Completed Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Condition: HIV Infections
Interventions: Drug: fosamprenavir;   Drug: COMBIVIR;   Drug: ritonavir;   Drug: TRIZIVIR
5 Terminated GW873140 In Combination With Combivir In HIV Infected Subjects
Condition: HIV Infection
Interventions: Drug: GW873140;   Drug: Combivir
6 Active, not recruiting Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
Conditions: HIV Infections;   Dyslipidemias;   Glucose Metabolism Disorders;   Metabolic Diseases;   Lipodystrophy;   Cardiovascular Disease
Interventions: Drug: Combivir (zidovudine [AZT] / lamivudine [3TC]);   Drug: Kaletra (lopinavir [LPVr])
7 Completed SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: zidovudine and lamivudine (Combivir®);   Drug: emtricitabine and tenofovir DF
8 Recruiting Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-Child Transmission (PMTCT)
Condition: HIV Infections
Interventions: Drug: Zidovudine and Lamivudine (Combivir);   Drug: Emtricitabine and Tenofovir (Truvada)
9 Completed Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Viread (tenofovir disoproxil fumarate );   Drug: Emtriva (emtricitabine);   Drug: Combivir (zidovudine + lamivudine);   Drug: Sustiva (efavirenz)
10 Recruiting Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-Partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
11 Active, not recruiting Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Trizivir;   Drug: Lamivudine/Zidovudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine
12 Active, not recruiting Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate
13 Suspended Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Lamivudine/Zidovudine;   Drug: Capravirine;   Drug: Nelfinavir mesylate
14 Active, not recruiting Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
Conditions: HIV Infections;   Tuberculous Meningitis
Intervention: Drug: Combivir and efavirenz
15 Completed Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy
Condition: HIV Infection
Intervention: Drug: Nelfinavir mesylate, 625 mg
16 Completed Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Atazanavir;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine
17 Completed A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate;   Drug: Efavirenz
18 Completed A Study of Single Dose NVP With 4 or 7 Day Course of Combivir for pMTCT - Treatment Options Preservation Study (TOPS)
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: Nevirapine (NVP);   Drug: Zidovudine (ZCV);   Drug: 3TC
19 Not yet recruiting Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
Conditions: HIV Transmission;   HIV Infections
Intervention: Drug: tenofovir + emtricitabine, lopinavir/ritonavir
20 Completed Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women
Condition: HIV Infections
Intervention: Drug: Atazanavir + Ritonavir + Combivir

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services